Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Noack

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Neuropharmacology|August 7, 2018
The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsyClaudia Brandt, Petra Hillmann, Andreas Noack, et al.
Cancer Research|March 5, 2008
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasisJan-Hendrik Egberts, Vera Cloosters, Andreas Noack, et al.
Journal of Synchrotron Radiation|November 20, 2024
Development of MHz X-ray phase contrast imaging at the European XFELJayanath C P Koliyadu, Daniel Moško, Eleni Myrto Asimakopoulou, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Neuropharmacology|August 7, 2018
The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsyClaudia Brandt, Petra Hillmann, Andreas Noack, et al.
Cancer Research|March 5, 2008
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasisJan-Hendrik Egberts, Vera Cloosters, Andreas Noack, et al.
Journal of Synchrotron Radiation|November 20, 2024
Development of MHz X-ray phase contrast imaging at the European XFELJayanath C P Koliyadu, Daniel Moško, Eleni Myrto Asimakopoulou, et al.
Pageof 3